ZNF433 displayed negative correlations with immune regulators and checkpoint molecules in BLCA and GBM, suggesting an immunosuppressive function, while positive associations in DLBC and PRAD implied immune activation. Here, ZNF433 is linked to prostate adenocarcinoma.